_version_ 1783687473325408256
author Sattar, Yasar
Mukuntharaj, Pradeeksha
Attique, Hassan
Ullah, Waqas
Sana, Muhammad Khawar
Zaher, Nathan
Suleiman, Abdul-Rahman M.
Mehmood, Maham
Panchal, Ankur
Mir, Tanveer
Nadeem, Muhammad
Zghouzi, Mohamed
Ahmad, Bachar
Hakim, Zaher
Gardi, Delair
Ali, Omar E.
Alhatemi, Ghaith
Mohamed, Mohamad
Elgendy, Islam
Mamas, Mamas
Alraies, M. Chadi
author_facet Sattar, Yasar
Mukuntharaj, Pradeeksha
Attique, Hassan
Ullah, Waqas
Sana, Muhammad Khawar
Zaher, Nathan
Suleiman, Abdul-Rahman M.
Mehmood, Maham
Panchal, Ankur
Mir, Tanveer
Nadeem, Muhammad
Zghouzi, Mohamed
Ahmad, Bachar
Hakim, Zaher
Gardi, Delair
Ali, Omar E.
Alhatemi, Ghaith
Mohamed, Mohamad
Elgendy, Islam
Mamas, Mamas
Alraies, M. Chadi
author_sort Sattar, Yasar
collection PubMed
description
format Online
Article
Text
id pubmed-8091385
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Cardiology Foundation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80913852021-05-03 META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION Sattar, Yasar Mukuntharaj, Pradeeksha Attique, Hassan Ullah, Waqas Sana, Muhammad Khawar Zaher, Nathan Suleiman, Abdul-Rahman M. Mehmood, Maham Panchal, Ankur Mir, Tanveer Nadeem, Muhammad Zghouzi, Mohamed Ahmad, Bachar Hakim, Zaher Gardi, Delair Ali, Omar E. Alhatemi, Ghaith Mohamed, Mohamad Elgendy, Islam Mamas, Mamas Alraies, M. Chadi J Am Coll Cardiol Spotlight on Special Topics American College of Cardiology Foundation. Published by Elsevier Inc. 2021-05-11 2021-05-03 /pmc/articles/PMC8091385/ http://dx.doi.org/10.1016/S0735-1097(21)04513-7 Text en © 2021 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Spotlight on Special Topics
Sattar, Yasar
Mukuntharaj, Pradeeksha
Attique, Hassan
Ullah, Waqas
Sana, Muhammad Khawar
Zaher, Nathan
Suleiman, Abdul-Rahman M.
Mehmood, Maham
Panchal, Ankur
Mir, Tanveer
Nadeem, Muhammad
Zghouzi, Mohamed
Ahmad, Bachar
Hakim, Zaher
Gardi, Delair
Ali, Omar E.
Alhatemi, Ghaith
Mohamed, Mohamad
Elgendy, Islam
Mamas, Mamas
Alraies, M. Chadi
META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title_full META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title_fullStr META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title_full_unstemmed META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title_short META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
title_sort meta-analysis of safety and efficacy of renin angiotensin aldosterone system inhibitors in covid-19 population
topic Spotlight on Special Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091385/
http://dx.doi.org/10.1016/S0735-1097(21)04513-7
work_keys_str_mv AT sattaryasar metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT mukuntharajpradeeksha metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT attiquehassan metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT ullahwaqas metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT sanamuhammadkhawar metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT zahernathan metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT suleimanabdulrahmanm metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT mehmoodmaham metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT panchalankur metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT mirtanveer metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT nadeemmuhammad metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT zghouzimohamed metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT ahmadbachar metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT hakimzaher metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT gardidelair metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT aliomare metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT alhatemighaith metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT mohamedmohamad metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT elgendyislam metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT mamasmamas metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population
AT alraiesmchadi metaanalysisofsafetyandefficacyofreninangiotensinaldosteronesysteminhibitorsincovid19population